ENZON PHARM - Dusseldorf Stock Exchang
ENZON PHARM - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
ENZON PHARM - Dusseldorf Stock Exchang (EZ1) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.146x
Based on the latest financial reports, ENZON PHARM - Dusseldorf Stock Exchang (EZ1) has a cash flow conversion efficiency ratio of 0.146x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€404.00K) by net assets (€2.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ENZON PHARM - Dusseldorf Stock Exchang - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how ENZON PHARM - Dusseldorf Stock Exchang's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ENZON PHARM - Dusseldorf Stock Exchang Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ENZON PHARM - Dusseldorf Stock Exchang ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Asia Siyaka Commodities Ltd
CM:ASIYN0000
|
N/A |
|
CHINA WINDPOWER - Dusseldorf Stock Exchang
DU:HK51
|
N/A |
|
CHU KONG PETRO GAS
BE:YCK
|
N/A |
|
AIRTEL UGANDA LIMITED
USE:AIRTELUGANDA
|
N/A |
|
BEIJING JINGKELNG-H
MU:G2M
|
N/A |
|
Indonesia Prima Property Tbk
JK:OMRE
|
-0.008x |
|
Valens Semiconductor Ltd.
NASDAQ:VLN-WT
|
N/A |
|
Bunnys Limited
KAR:BNL
|
N/A |
Annual Cash Flow Conversion Efficiency for ENZON PHARM - Dusseldorf Stock Exchang (2016–2023)
The table below shows the annual cash flow conversion efficiency of ENZON PHARM - Dusseldorf Stock Exchang from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €3.50 Million | €1.30 Million | 0.372x | +292.49% |
| 2022-12-31 | €3.41 Million | €-659.00K | -0.193x | -87.94% |
| 2021-12-31 | €4.87 Million | €-501.00K | -0.103x | -99.33% |
| 2020-12-31 | €7.36 Million | €-380.00K | -0.052x | -104.53% |
| 2019-12-31 | €6.05 Million | €6.91 Million | 1.140x | +1848.23% |
| 2018-12-31 | €14.99 Million | €-978.00K | -0.065x | -109.22% |
| 2017-12-31 | €9.14 Million | €6.47 Million | 0.708x | +181.30% |
| 2016-12-31 | €10.33 Million | €2.60 Million | 0.252x | -- |